Randomized Phase II/III Study of R-CHOP +/- Venetoclax in Previously Untreated MYC/BCL2 Double Expressor Diffuse Large B Cell Lymphoma (DLBCL): Alliance A051701
- Citation:
- J Clin Oncol vol 24 (16_suppl) 7012
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180888 (SWOG
- Corr. Author:
- Authors:
- Jeremy S. Abramson Susan Geyer Levi Pederson Sharmila Giri Eric D. Hsi Richard F. Little Steven Gore Daniel Landsburg Hua-Jay Cherng Brad Kahl Neha Mehta-Shah Shira Dinner Jonathan W. Friedberg Nancy L. Bartlett John P. Leonard
- Networks:
- LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-MO011, MD001, NY018, PA121
- Study
- Alliance-A051701
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2/3
- Keywords: